Investing.com - Oramed announced first quarter earnings that beat analysts' expectations on Friday and revenue that was in line with forecasts.
The company reported earnings per share of $-0.08 on revenue of $700K. Analysts polled by Investing.com forecast EPS of $-0.09 on revenue of $700K. .
Oramed share's are down 84% for the year to date , still down 86.02% from its 52 week high of $13.73 set on Thursday, January 5, 2023.
Oramed follows other major Healthcare sector earnings this month
On Thursday, November 2, 2023, Eli Lilly reported third quarter EPS of $0.1 on revenue of $9.5B, compared with a forecasts for EPS of $-0.2 on revenue of $8.97B.
UnitedHealth earnings beat analysts' expectations on Friday, October 13, 2023, with third quarter EPS of $6.56 on revenue of $92.4B. Investing.com analysts forecast EPS of $6.33 on revenue of $91.42B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar